Jing Peng
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology top 10%
- Co-authors
- Mark MerchantHartmut KoeppenRichard M. NeveElicia PenuelTimothy R. WilsonYulei WangJeff SosmanYibing Yan
- Topics
- Cancer-related molecular mechanisms research (15 papers)MicroRNA in disease regulation (14 papers)RNA modifications and cancer (12 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Jing Peng
71 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Molecular Biology 1.6k
- Oncology 732
- Cancer Research 599
- Pulmonary and Respiratory Medicine 299
- Immunology 233
Countries citing papers authored by Jing Peng
This map shows the geographic impact of Jing Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Peng more than expected).
Fields of papers citing papers by Jing Peng
This network shows the impact of papers produced by Jing Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Peng. The network helps show where Jing Peng may publish in the future.
Co-authorship network of co-authors of Jing Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Jing Peng. A scholar is included among the top collaborators of Jing Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Peng. Jing Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 8 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 6 | |
| 7 | 3 | |
| 8 | 6 | |
| 9 | 2 | |
| 10 | High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas | 2 |
| 11 | HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma | 0 |
| 12 | 14 | |
| 13 | 13 | |
| 14 | 6 | |
| 15 | 5 | |
| 16 | 54 | |
| 17 | 49 | |
| 18 | 110 | |
| 19 | Multitargeted kinase inhibition and sustained biological effects of CHIR-258 contribute to enhanced preclinical efficacy | 1 |
| 20 | 33 |
About Jing Peng
Jing Peng is a scholar working on Cancer Research, Molecular Biology and Immunology, having authored 77 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (14 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Cancer Research (599 citations), Oncology (732 citations) and Molecular Biology (1.6k citations). Jing Peng has collaborated with scholars based in China, United States and France. Frequent co-authors include Mark Merchant, Hartmut Koeppen, Richard M. Neve, Elicia Penuel, Timothy R. Wilson, Yulei Wang, Jeff Sosman, Yibing Yan, John G. Moffat and Antoni Ribas. Their work appears in journals such as Nature, Advanced Materials and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.